Cara Therapeutics to Present at Upcoming Investor Conferences
STAMFORD, Conn., Nov. 02, 2022 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that members of its Executive Leadership Team will present at the following investor conferences:
Related news for (CARA)
- Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
- Bicara Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split
- 24/7 Market News Snapshot 18 December, 2024 – Cara Therapeutics, Inc. (NASDAQ:CARA)
- Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement